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 The objective of this study was to assess and analyze the prescribing pattern, rationality of 
antibacterial, to study medication related problems and resistance/sensitivity patterns of 
antibiotics in patients with urinary tract infections. The observational prospective study was 
conducted in 100 patients with UTI at MVJ medical college and research hospital, Bangalore, 
India for six months. All required patient data were collected in specially designed case report 
form. Prescribing patterns, medication related problems and rationality were assessed. The 
average number of drug per encounter was 7.02. More than 63% of prescription had more 
than five drugs. Brand names of drug were prescribed more than the generic names. 
Fluroquinolones (norfloxacin) was mostly prescribed. Female population was more. Age 
group of >58 years old was most prevalent. Monotherapy of antibiotic was more than 
combination therapy. Most of the possible drug interactions were moderate type. Norfloxacin 
was most frequently interacting antibiotic. No significant medication errors were identified. 
Rationality was assessed to be rational. The most common type of pathogen was E.coli. 
Antibacterial prescribing patterns and rationality of the medications were appropriate but, 
using drug brand names can increase the chance of medication related problems. Higher 
number of comorbidities was leading to polypharmacy which can increase possibility of drug-
drug interactions therefore there is an increased requirement for close monitoring and 
management of these possible interactions. E. coli, K. pneumoniae and P. aeruginosa were 
more sensitive to nitrofurantoin, amikacin and norfloxacin therefore these may be the 
antibiotics of choice for the treatment of community-acquired UTIs. 
Please cite this article in press as Anamika Chalise et al. Utilization of Antibiotics in Patients with Urinary Tract Infections – A 
Study. Indo American Journal of Pharmaceutical Research.2017:7(08). 
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INTRODUCTION 
Urinary Tract Infection (UTI) is an infection that affects the urinary tract which includes the kidneys (pyelonephritis), bladder 
(cystitis) and urethra. [1]
 
UTIs are classified as complicated (with structural abnormalities) and uncomplicated (no structural or 
functional abnormalities).
 
Symptoms of UTIs include dysuria, urgency, frequency, nocturia and suprapubic heaviness, fever, and flank 
pain. [2] 
The main objective of this study was to understand the rationality of antibiotics being used for treatment of UTI by 
conducting a drug utilization study. Antibiotic resistance is becoming a threat for the public health, lives of hospitalized individual and 
patients with chronic conditions therefore there is a need for antibiotic guidelines to prevent such resistance also to improve the 
patient’s therapeutic outcome. 
UTI can affect both male and female of all the ages but prevalence is higher in women than men. [3]
 
The global UTI 
prevalence is 0.7 %. [4] UTI is the second most common infectious presentation in community practice. Worldwide, about 150 million 
people are diagnosed with UTI each year. [5]  
Uncomplicated UTI can be managed with short course (3 days) therapy with either trimethoprim-sulfamethoxazole or a 
fluoroquinolone. Complicated infections require longer treatment periods (2 weeks) usually with one of above mentioned agents. [6] 
Drug utilization was defined by World Health Organization (WHO) as “marketing, distribution, prescription, and use of 
drugs in society, with special emphasis on the resulting medical, social and economic consequences”. [7] 
Prescription pattern monitoring studies are drug utilization studies with the main focus on prescribing, dispensing and 
administering of drugs to facilitate the rational use of drugs in a population and promote appropriate use of monitored drugs and 
reduction of abuse or misuse of monitored drugs. According to WHO, rational use of medicines requires that “patients receive 
medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time, 
and at the lowest cost to them and their community.” [8] 
Medication related problems are defined as “an event or circumstance involving drug therapy that actually or potentially 
interfere with desired health outcomes”. Medication related problem is the third or fourth leading cause of death in the elderly 
worldwide. [9] 
 
OBJECTIVES 
The primary objectives of this study were to assess and analyze the prescribing pattern of antibacterial and to study the 
medication related problems in patients with urinary tract infections. The secondary objectives were to study resistance and sensitivity 
pattern of antibiotics and to assess rationality of medications prescribed for treating patients with urinary tract infections. 
 
METHODOLOGOY  
STUDY DESIGN: 
Prospective observational study 
 
STUDY SITE: 
Department of General Medicine and Obstetrics and Gynecology, MVJ Medical College and Research Hospital, Hoskote, 
Bangalore 
 
STUDY POPULATION: 
In-patients in General Medicine and Obstetrics and Gynecology Departments diagnosed with UTI 
 
SAMPLE SIZE: 100 patients 
 
STUDY PERIOD: Six months  
 
SOURCE OF DATA: 
Patient case sheets, culture sensitivity report form, case report form, informed consent form, prescriptions, standard database 
references (i.e.  Lexicomp, Medscape, Drugs.com), standard textbook references (i.e. Pharmacotherapy: A Pathophysiologic Approach 
by Joseph T. Dipiro, Stockley's Drug Interactions by Ivan H. Stockley) 
 
HUMAN ETHICAL APPROVAL: 
Human ethical clearance was obtained for carrying out the research work from Ethical Committee of MVJ Medical College 
& Research Hospital, Hoskote, Bangalore with ethical clearance number: Central Research/MVJ MC & RH/01/2017 
 
INCLUSION CRITERIA:  
• All in-patients who were diagnosed with urinary tract infections  
• All in-patients over 18 years of age 
• The patients diagnosed with UTIs along with/without other comorbid disease or disorders 
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EXCLUSION CRITERIA: 
• The in-patients with urinary tract infection who are unwilling to participate in the study 
• Those patients who are unable to provide the informed consent 
 
PROCEDURE 
• A Prospective – Observational Study was conducted in M.V.J Medical College and Research Hospital 
• The patients who were admitted in General Medicine or Obstetrics and Gynecology in-patient wards and met the study criteria 
were enrolled in the study 
• Informed consent from the patient or his/her legal representative was obtained 
• Clinical, demographic, medication and laboratory data were collected and recorded in case report form on day one, day three and 
day seven 
• Medication related problems such as drug-drug interactions, drug duplication, dose, route of administration, frequency, duration 
of therapy and dosage form were assessed from day zero to day seven by using standard references and databases 
• The prescribing pattern was assessed and analyzed for parameters such as choice, dose, frequency, route of administration and 
dosage form, before and after culture sensitivity was done on day one and day three to check whether it’s according to the hospital 
treatment guidelines or not 
• Drug induced ADR was monitored on day three using ADR monitoring scale (WHO scale causality assessment) 
• Rationality of medications used was assessed using WHO criteria 
• All the data were analyzed using descriptive statistics 
 
RESULTS 
100 patients were enrolled in the study in which number of females was more than males (53% and 47%). Most of the 
patients were in the age group of above 58 years old (37%) which out of these 23 are males and 14 are females. The average age of the 
study population was 47.67. Number of patients who were admitted in the General Medicine ward was more than number of patients 
who were admitted in Obstetrics and Gynecology ward which are 69 patients and 31 patients respectively. 
It was found that most of the patients were suffering from lower UTI i.e. cystitis (72%, in which females were more than 
males) and 14% were suffering from upper UTI i.e. pyelonephritis (males more than females) and in the remaining patients type of 
UTI was unspecified.  The average age was 53.14 in cystitis population, 57.89 in pyelonephritis population and 32 in unspecified 
(females more than males).  
In 100 cases that were collected for this study 68 cases were with comorbid conditions (UTI along with other diseases) and 
remaining 32 cases were without any comorbid conditions (only UTI) and the most common type of comorbidity among the 68 cases 
was UTI with renal calculi (10 cases, 14.74%) as shown in table 1.  
 
Table 1: COMORBIDITY DISTRIBUTION (N=68). 
 
CONDITIONS NUMBER PERCENTAGE 
Renal Calculi 10 14.74% 
Benign Prostatic Hyperplasia (BPH) 8 11.76% 
Pelvic Inflammatory Disease 6 8.82% 
Hypertension (HTN) + Diabetes Mellitus (DM) 6 8.82% 
Diabetes Mellitus 4 5.88% 
Hypertension 4 5.88% 
Post-hysterectomy 4 5.88% 
Osteoarthritis 4 5.88% 
Catheterization 2 2.94% 
Post-Tuberculosis + BPH 2 2.94% 
Bronchitis + BPH 2 2.94% 
Ischemic Heart  Disease 2 2.94% 
Colitis 2 2.94% 
Thrombocytopenia 2 2.94% 
Anemia 2 2.94% 
Diarrhea 2 2.94% 
Hernia 2 2.94% 
Post-nephrectomy 2 2.94% 
HTN+ DM + Chronic Obstructive Pulmonary Disease 2 2.94% 
TOTAL 68 100% 
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Totally 137 antibiotics were prescribed for treatment of UTI in which number of patients who were prescribed with 
fluoroquinolones (66 patients, 48.18%) and cephalosporin (47 patients, 34.31%) were more than the number of patients prescribed 
with the other classes of antibiotics out of this, norfloxacin (35 patients, 25.54%) under the category of fluoroquinolones, cefixime (18 
patients, 13.13%) under the category of cephalosporins and amikacin (11 patients, 8.03%) under the category of aminoglycosides were 
prescribed more compared to other antibiotics for treatment of UTI as shown in table 2. 
 
Table 2: DISTRIBUTION OF ANTIBIOTICS USED UNDER EACH CLASS (N=137). 
 
S/N Antibiotic (generic name) Number Percentage Total % 
 FLUOROQUINOLONES  
1 Norfloxacin 35 25.54% 48.9% 
2 Ciprofloxacin 22 16.06% 
3 Ofloxacin 9 6.56% 
 CEPHALOSPORIN  
4 Cefixime 18 13.13% 34.3% 
5 Ceftriaxone 16 11.68% 
6 Cefotaxime 7 5.12% 
7 Cefoperazone 6 4.37% 
 AMINOGLYCOSIDES  
8 Amikacin 11 8.03% 8.03% 
 NITROFURANTOIN  
9 Nitrofurantoin 7 5.12% 5.12% 
 MACROLIDE  
10 Azithromycin 2 1.46% 1.46% 
 PENICILLIN  
11 Amoxicillin 2 1.46% 1.46% 
 LINCOSAMIDE  
12 Clindamycin 2 1.46% 1.46% 
 TOTAL 137 100% 100% 
 
For treatment of UTI the number of patients who were prescribed with monotherapy of antibiotics (59%) was more than the 
number of patients prescribed with combination therapy of antibiotics (41%).  
In monotherapy, fluoroquinolones (39 patients, 66.1%, in which norfloxacin 46.15% was prescribed most) and 
cephalosporins (14 patients, 23.73%, in which cefixime 28.16% was prescribed most) were prescribed more than other classes of 
drugs  and in combination therapy the combination of injection cefotaxime (1g) and tablet cefixime (200 mg) in 6 patients as well as 
the combination of tablet ofloxacin (200mg) with tablet ornidazole (600 mg) in other 6 patients were prescribed more than any other 
combination. Monotherapy of antibiotics was found to be used more in treatment of cystitis (63.17%) than pyelonephritis (12.56%) 
and unspecified type of UTI ( 23.73%) in which norfloxacin was the most frequently used antibiotic (in 22 patients). The antibiotic 
combination was more in treatment of cystitis (90%) comparing with pyelonephritis (10%) which in cystitis combination of tablet 
ofloxacin (200mg) and tablet ornidazole (600 mg) in 6 patients as well as combination of injection cefotaxime (1g) with tablet 
cefixime (200 mg) in 6 other patients were used more and in pyelonephritis combination of tablet cefoperazone (1g) and tablet 
norfloxacin (400mg) in 2 patients as well as combination of injection ceftriaxone (1g) with tablet norfloxacin (400mg) in 2 other 
patients were prescribed. 
Along with antibiotics used in treatment of cystitis, pyelonephritis and unspecified UTI, other drugs (407 non-antibacterial 
drugs) were also prescribed for different indications in which dihydrogen sodium citrate (in cystitis 51 patients and in pyelonephritis 6 
patients), pantoprazole (in cystitis 45 patients and in unspecified 2 patients) and paracetamol (in cystitis 29 patients and unspecified 10 
patients) were the most prescribed non-antibacterial. Out of 100 prescriptions, 131 drug-drug interactions (with antibacterial) were 
possible in which 88 were moderate type, 32 were minor and 10 were major as shown in table 3. From 131 possible interactions, 60 
drug-drug interaction combinations were reported to the prescribers in which the most common management of interactions was to 
change the frequency of the drug to be administered daily (26 cases, 49.05%), followed by adjustment of dose of the interacting drugs 
(20 cases, 41.52%), changing the route of administration of the drug (3 cases, 5.66%) and use of an alternative drug (2 cases, 3.77%).  
The antibiotic found interacting in majority of the cases was norfloxacin (35.13%) and ciprofloxacin (32.44%) in which the most 
common pattern of major drug interactions (2 patterns) was between norfloxacin and tramadol (in 7 cases), in moderate drug 
interactions (11 patterns) was between amikacin and diclofenac (in 6 cases) and in minor drug interactions (3 patterns). 
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Table 3: DRUG INTERACTIONS – INTERVENTIONS (N=61) AND MANAGEMENT BASED ON TYPES (N=53). 
 
The collected 100 prescriptions were analyzed for the medication errors as shown in table 4 in which drug duplication was 
observed and reported in two prescriptions but as the benefits of this combination overweighed the possible risks, the prescriber 
carried on with the same combination of drugs. 
 
Table 4: MEDICATION ERRORS (N=74). 
 
Factors Number 
Drug duplication
* 
2 
Sound alike medications 0 
Errors in dose 0 
Errors in dosage form 0 
Errors in route of administration 0 
Errors in frequency 0 
Errors in duration of therapy 0 
*Drug duplications between flavoxate and tolterodine. Both of them belong to the same category which is anticholinergics/ 
antispasmodics. 
 
The prescribing patterns of 100 prescriptions were analyzed for factors that are shown in table 5 and 6  in which it was seen 
that brand names were used more than generic names and 72 antibiotics were from the WHO essential antibiotics list.  
 
Table 5: PRESCRIBING PATTERNS DISTRIBUTION (N=100). 
 
Factors Number Percentage 
Brand names 649 91.66% 
Generic names 59 8.33% 
TOTAL 708 100% 
PARENTERAL DOSAGE FORM 
Intravenous 170 86.74% 
Intramuscular 18 9.18% 
Subcutaneous 8 4.08% 
TOTAL 196 100% 
Essential antibiotics used 72 52.56% 
Nonessential antibiotics used 65 47.44% 
TOTAL 137 100% 
Polypharmacy average 
Patients are prescribed an average of 7.22 drugs 
per prescription. 63% of the prescriptions were 
seen to have more than 5 drug prescribed. 
 
 
 
 
 
 
 
 
 
 
 
Type of UTI 
No. of Interaction 
Identified 
Interventions (Reported) Management (Result) 
Yes No Considered Not Considered 
Cystitis 112 
51 
(10 major + 
41 moderate) 
61 
(31 minor + 30 
moderate) 
45 
6 
(patients left the hospital against 
medical advice) 
Pyelonephritis 19 
10 
(moderate) 
10 
(2 minor + 8 
moderate) 
8 
2 
(patients left the hospital against 
medical advice) 
Unspecified 0 0 0 0 0 
Total 131 61 71 53 8 
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Figure 2: ANTIMICROBIALS SENSITIVITY 
PATTERN (N=92) 
Table 6: PRESCRIPTION AND UTILIZATION PATTERN OF ANTIBIOTICS (N=100). 
 
Question pattern Response pattern Frequency (%) 
Pattern of antibiotics prescription Single antibiotic 59 59% 
Multiple antibiotics 41 41% 
Information about the directions* for antibiotic use Complete direction 94 94% 
Incomplete direction 6 6% 
Clinical test for prescribing antibiotics With test 92 92% 
Without test 8 8% 
Completion of full antibiotic course Yes 92 92% 
No 8 8% 
Patient’s compliance Disease recovery 88 88% 
Incompliance 12 12% 
*Dose, frequency, rout of administration, duration, diet. 
 
 Rationality of the prescribed antibiotics were assessed and found to be rational by comparing with the guidelines (i.e. hospital 
antibiotics policy of OBG and GM departments, standard textbooks and online databases) for the factors like dose, dosage form, 
frequency, duration of therapy, route of administration and therapy indications for the prescribed drug. 
The urine analysis and culture sensitivity test has been done for 92 patients who were enrolled in the study in which the most 
common type of pathogen found was Escherichia coli (in 66 patients) which was more in males (35 patients) than females followed 
by Klebsiella pneumonia (in 16 patients) and Psueodomonas aeruginosa (in 6 patients) that were more in females than males. The 
frequency of all the type of pathogens were more in cystitis comparing with pyelonephritis, which were: Escherichia coli (61.76%), 
Klebsiella pneumonia (23.52%), Psueodomonas aeruginosa (8.83%) and Staphylococcous aureus (5.89%). E. coli was causative 
pathogen in 66 cases where it was mostly resistant to the ampicillin, amoxicillin, cefotaxim and ceftriaxone antibiotics and K. 
pneumonia was resistant to ampicillin, cloxacillin, norfloxacin and ofloxacin antibiotics as demonstrated in figure 1 and E. coli was 
sensitive to the cotrimoxazole, norfloxacin, nitrofurantoin as well as amikacin antibiotics and K. pneumonia, was sensitive to 
cefotaxim, cotrimoxazole, nitrofurantoin and amikacin as shown in figure 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
The number of females who were diagnosed with UTI (53%) was more than males (47%) and the most common age group 
was 58 years old and above (37%). This result was similar to the studies done by following: Mohammed Akram et al females 
(66.66%) and males (43.44%) [10]; Sunil S Gidamudi et al female (55.6%) and male (44.4%) and the most common age group was 
patients in 40-60 years age group (40.7%).[11] In this study most of the patients were with comorbid conditions in which the most 
common comorbid conditions were diabetes mellitus (17.64%), hypertension (17.64%), renal calculi (14.74%), and benign prostatic 
hyperplasia (11.76%). In a study by Sunil S Gidamudi et al the similar results was found that comorbidity was more (90.74%) in 
which the most common comorbid conditions were diabetes mellitus (32.65%), hypertension (26.53%) and renal/ureteric calculi 
(12.25%). [11] 
The prescription pattern for 100 patients were reviewed in this study where totally 137 antibiotics were prescribed in which 
quinolones [fluoroquinolones] (48.18%) were mostly prescribed. Syed Zahed pasha et al carried out a similar study with the same 
result i.e. quinolones (36.55%) [12] and Cenk Aypak et al also conducted a study with almost similar results i.e. prescribed 
fluoroquinolones (77.9%). [13] 
Figure 1: ANTIMICROBIALS RESISTANCE 
PATTERN (N=92) 
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In this study majority of patients were prescribed with monotherapy of antimicrobials (59%). In the study that was done by 
Sah Om P et al the results stated that commonly used type of therapy for patients was monotherapy of antimicrobials (62.9%). [14] 
Combination of antibiotics (two or more) was prescribed in 41% of prescriptions. Among the prescribed antibiotics, 94% had 
complete direction for the use of antibiotics, 92% patients completed full course of antibiotics, 92% prescriptions had clinical test for 
using antibiotics and patient’s disease recovery 88%. Mohitosh Biswas et al conducted a study that had similar results i.e. two or more 
antibiotics were prescribed in 25.44% of prescriptions, prescriptions with complete direction for antibiotics use (57%), 64.22% 
patients completed full course of antibiotics, prescriptions with no clinical test for using antibiotics  (83%) and the percentage of 
patient’s disease recovery was 61.78%. [15] 
The most common pathogen was E. coli (71.74%) followed by K. pneumoniae (17.39%), P. aeruginosa (6.53%) and S. 
aureus (4.34%). In a study by Mohammed Akram et al similar results [10] were found that E. coli (61%), K. pneumoniae (22%), P. 
aeruginosa (4.0%), S. aureus (7.0%) and same results in a study by Sah Om P et al [14] that is E. coli (64.4%), Klebsiella species 
(13.3%), Pseudomonas species (3.8%).  E. coli was resistant to ampicillin (90.90%), amoxicillin (87.87%), cefotaxim (81.81%) and 
(78.78%). K. pneumoniae was resistant to ampicillin (87.5%) but E. coli was sensitive to norfloxacin (90.90%), amikacin (87.87%) 
and nitrofurantoin (87.87%), amoxicillin (6.06%) and ceftriaxone (3.03%). Sunil S Gidamudi et al have done a research with almost 
similar results i.e. E. coli was resistant to ampicillin (86.96%) and ceftriaxone (82.61%) but sensitive to amikacin (91.3%) and 
ceftriaxone (13.04%). [11] 
 
CONCLUSION 
Prescribing pattern of antibacterials and rationality of the medications used for treating patients with UTIs was appropriate 
and according to the standard guidelines but using brand names for prescribing drugs can increase the chance of medication related 
problems. Higher number of comorbidities was leading to polypharmacy which is a precursor for increasing possibility of drug-drug 
interactions, in return there is an increased requirement for close monitoring and management of these possible interactions. E. coli, K. 
pneumoniae and P. aeruginosa were more sensitive to nitrofurantoin, amikacin and norfloxacin therefore these may be the antibiotics 
of choice for the treatment of community-acquired UTIs. Antibiotic resistance is becoming a threat for the public health, lives of 
hospitalized individual and patients with chronic conditions therefore there is a need for antibiotic guidelines to prevent such 
resistance. 
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ABBREVIATIONS 
ADR : Adverse Drug Reaction 
BPH : Benign Prostatic Hypertrophy 
DM : Diabetes Mellitus 
GM : General Medicine 
HTN : Hypertension 
OBG : Obstetrics and Gynecology 
UTI : Urinary Tract Infection 
WHO : World Health Organization 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                   
www.iajpr.com 
P
ag
e6
5
5
 
Vol 7, Issue 08, 2017.                                                    Anamika Chalise et al.                                                  ISSN NO: 2231-6876 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REFERENCES 
1- Lane DTakhar S. Diagnosis and Management of Urinary Tract Infection and Pyelonephritis. Emergency Medicine Clinics of North 
America, 2011; 29(3):539-552. 
2- DiPiro, Joseph T. Pharmacotherapy: A Pathophysiologic Approach. New York: McGraw-Hill Medical, 2011; 8:1995. 
3- Arul K, Dileesh K, Vijayan M. A Cross Sectional Study on Distribution of Urinary Tract Infection and Their Antibiotic Utilisation 
Pattern in Kerala. International Journal of PharmTech Research. 2012; 4(3):1309-1316. 
4- Tandogdu Z, Wagenlehner F. Global epidemiology of urinary tract infections. Current Opinion in Infectious Diseases. 2016; 
29(1):73-79. 
5- Lane, DR; Takhar, SS (August 2011). "Diagnosis and management of urinary tract infection and pyelonephritis.". Emergency 
medicine clinics of North America. 29 (3): 539–52. 
6- Common Side Effects of Amikin (Amikacin) Drug Center - RxList [Internet]. RxList. 2017 [cited 31 May 2017]. Available from: 
http://www.rxlist.com/amikin-side-effects-drug-center.html 
7- Hemminki E, Ghodse H, Khan I. Factors influencing prescribing. Psychoactive Drugs: Improving Prescribing Practices. Geneva: 
World Health Organization; 1988. p. 22-35. 
8- Pradhan S, Shewade D, Shashindran C, Bapna J. Drug utilization studies. Natl Med J India 1988; 1:185-9. 
9- Soumerai SB. Factors influencing prescribing. Aust J Hosp Pharm 1988; 18(3):9-16. 
10- Akram M, Shahid M, Khan A. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M 
C Hospital Aligarh, India. Annals of Clinical Microbiology and Antimicrobials. 2007; 6(1):4. 
11- Gidamudi S, Jadhav S, Khanwelkar C, Thorat V, Desai R, Naik H. Antimicrobial Utilization Pattern Of Urinary Tract Infection In 
Tertiary Care Hospital. Asian Journal Of Pharmaceutical And Clinical Research. 2015; 8(6):161-164. 
12- Syed Zahed pasha G. prescribing pattern and use of antibiotics and combination of antibiotics in a tertiary care teaching hospital. 
Indo American Journal of Pharmaceutical Research [Internet]. 2014 [cited 7 August 2016]; 4(7):3172-3181. Available from: 
http://www.scopemed.org/?mno=167980. 
13- Aypak C, Altunsoy A, Düzgün N. Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone 
resistance: a prospective observational study. Annals of Clinical Microbiology and Antimicrobials. 2009; 8(1):27. 
14- Sah Om P.*, Danegulu Ranjana, Khadka Jagat. Prescribing and sensitivity patterns of antimicrobials in uncomplicated urinary tract 
infections in females. Journal of Drug Delivery & Therapeutics; 2014, 4(2), 1-8. 
15- Mohitosh Biswas, Debendra Nath Roy, Afsana Tajmim. Prescription antibiotics for outpatients in Bangladesh: a cross-sectional 
health survey conducted in three cities. Annals of Clinical Microbiology and Antimicrobials 2014, 13:15. Available from: 
http://www.annclinmicrob.com/content/13/1/15. 
 
 
 
 
 
 
 
   
54878478451170825 
 
 
